Overall the proportion of subjects with a 50% reduction in seizure frequency was 23%, 34%, and 40% for placebo, lacosamide 200 mg/ day and lacosamide 400 mg/ day.
Krampide sagedus vähenes 50% võrra 23% platseeboravimit, 34% lakosamiidi 200 mg/ päevas ja 40% lakosamiidi 400 mg/ päevas saanutel.